Target intelligence / Profile preview

Sulfonated polyvinyl alcohol hydrogel matrix (S-PVA hydrogel)

Target
S-PVA hydrogel
Molecular classification
Other (Synthetic polymer hydrogel)
01

Overview

A sulfonated polyvinyl alcohol (S-PVA) hydrogel matrix is a specialized drug delivery platform designed to sequester and release positively charged (cationic) therapeutic agents. The matrix is composed of a polyvinyl alcohol backbone that has been chemically modified with sulfonic acid groups, which impart a permanent negative charge to the polymer network (Mandal et al., 2014, Journal of Applied Polymer Science). This anionic environment allows for high-capacity loading of cationic drugs through strong electrostatic interactions, effectively acting as an ion-exchange resin (Atta et al., 2015, Journal of Molecular Liquids). Upon administration, the release of the drug is triggered by the exchange of the drug cations with endogenous ions, such as sodium or potassium, found in physiological fluids (Peppas et al., 2000, European Journal of Pharmaceutics and Biopharmaceutics). This mechanism provides a controlled, sustained release profile that can be tuned by adjusting the degree of sulfonation or the crosslinking density of the hydrogel. S-PVA hydrogels are frequently investigated for applications in wound healing, transdermal delivery, and localized chemotherapy due to their biocompatibility and high water content. The system's performance is highly dependent on the ionic strength of the surrounding environment, which dictates the rate of ion exchange and subsequent drug diffusion.

Other names
Sulfonated PVAS-PVAAnionic PVA hydrogelSulfonated poly(vinyl alcohol)Cation-exchange hydrogel matrix
02

Mechanism of action

Electrostatic sequestration of cationic drugs followed by ion-exchange mediated release in physiological environments.

03

Biological functions

Other (Drug delivery and controlled release)
04

Disease associations

Other (Wound management)Other (Localized infection)Other (Cancer)
05

Safety considerations

Potential for burst releaseResidual crosslinking agents toxicityLocal irritation due to acidic sulfonic groupsBiocompatibility of degradation products
06

Interacting drugs

Lidocaine

5 more in the full profile.

07

Biomarkers

Drug concentration in plasmaLocal pHSwelling ratio of the hydrogel

Beyond the preview

Go deeper on Sulfonated polyvinyl alcohol hydrogel matrix (S-PVA hydrogel).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sulfonated polyvinyl alcohol hydrogel matrix (S-PVA hydrogel).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call